• Conference Proceeding

Cost-Effectiveness of Dabigatran Etexilate for the Secondary Prevention of Recurrent Deep Vein Thrombosis and Pulmonary Embolism in the United Kingdom

Citation

Wolowacz, S., Brockbank, J., Sunderland, T. J., & Gonschior, A. K. (2013). Cost-Effectiveness of Dabigatran Etexilate for the Secondary Prevention of Recurrent Deep Vein Thrombosis and Pulmonary Embolism in the United Kingdom. In [16], pp. A526–A526. .

Abstract